Position of COMT inhibition in the treatment of Parkinson's disease

被引：0

|

作者：

Gordin, AR ^{[1
]}

Kaakkola, T

Teräväinen, H

机构：

[1] Orion Pharma, Res Ctr, Espoo, Finland

[2] Univ Helsinki, Dept Neurol, Helsinki, Finland

来源：

PARKINSON'S DISEASE | 2003年 / 91卷

关键词：

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

收藏

页码：237 / 250

页数：14

相关论文

共 50 条

[1] COMT inhibition in the treatment of Parkinson’s disease
H. M. Ruottinen
U. K. Rinne
Journal of Neurology, 1998, 245 : P25 - P34
[2] COMT inhibition in the treatment of Parkinson's disease
Ruottinen, HM
Rinne, UK
JOURNAL OF NEUROLOGY, 1998, 245 (Suppl 3) : P25 - P34
[3] The role of COMT inhibition in the treatment of Parkinson's disease
Poewe, W
NEUROLOGY, 2004, 62 (01) : S31 - S38
[4] COMT inhibition in Parkinson's disease
Olanow, CW
Obeso, JA
NEUROLOGY, 2000, 55 (11) : S1 - S1
[5] Relevance of MAO and COMT inhibition to the treatment of Parkinson's disease
Jenner, P
FOCUS ON DEPRESSION AND ANXIETY, 1996, 7 (04): : 83 - 83
[6] COMT-inhibition: An important option in treatment of Parkinson's disease
Reichmann, H
AKTUELLE NEUROLOGIE, 2005, 32 : S297 - S298
[7] COMT inhibition in the treatment of Parkinson's disease: Neuroprotection and future perspectives
Kostic, VS
FRONTIERS IN CLINICAL NEUROSCIENCE: NEURODEGENERATION AND NEUROPROTECTION: A SYMPOSIUM IN ABEL LAJTHA'S HONOUR, 2004, 541 : 75 - 90
[8] COMT inhibition in Parkinson's disease: Rationale and clinical relevance
Deleu, D
ACTA NEUROLOGICA BELGICA, 2000, 100 (01) : 5 - 7
[9] Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease
Ariel Gordin
David J. Brooks
Journal of Neurology, 2007, 254 : IV37 - IV48
[10] Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease
Gordin, Ariel
Brooks, David J.
JOURNAL OF NEUROLOGY, 2007, 254 (Suppl 4) : 37 - 48

← 1 2 3 4 5 →